Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.63 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.63 |
| ▸ | MEN1 | O00255 | 1/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.63 |
| ▸ | LMNA | P02545 | 1/20 | 0.63 |
| ▸ | DGKA | P23743 | 1/20 | 0.55 |
| ▸ | FAAH | O00519 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | ENPP2 | Q13822 | 4/20 | 0.44 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.44 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.44 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.44 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.44 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.44 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.44 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.44 |
| ▸ | PRKCA | P17252 | 3/20 | 0.44 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.44 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.44 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9703651 | 0.85 | KDM4E (0.67) | KDM4EDUSP3MEN1KMT2ALMNA | |
| SCHEMBL28646767 | 0.84 | KDM4E (0.55) | KDM4EDUSP3MEN1KMT2ALMNA | |
| Glyceryl Monostearate SCHEMBL27848861 | 0.83 | LMNA (0.90) | KDM4EDUSP3MEN1KMT2ALMNA | |
| Glyceryl Monostearate SCHEMBL11581792 | 0.83 | LMNA (0.90) | KDM4EDUSP3MEN1KMT2ALMNA | |
| Monoctanoin Component A SCHEMBL27198866 | 0.83 | LMNA (0.90) | KDM4EDUSP3MEN1KMT2ALMNA | |
| SCHEMBL29110923 | 0.83 | LMNA (0.90) | KDM4EDUSP3MEN1KMT2ALMNA | |
| SCHEMBL3024584 | 0.83 | LMNA (0.90) | KDM4EDUSP3MEN1KMT2ALMNA | |
| SCHEMBL27962592 | 0.83 | LMNA (0.90) | KDM4EDUSP3MEN1KMT2ALMNA | |
| SCHEMBL28086891 | 0.83 | LMNA (0.90) | KDM4EDUSP3MEN1KMT2ALMNA | |
| Dodecane SCHEMBL21051235 | 0.82 | KDM4E (0.55) | KDM4EDUSP3MEN1KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250319013-A1 | THICKENING COMPOSITION FOR THICKENING POLAR OR NON-POLAR OILS | SOC DEXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) | 2025-10-16 | — | — | US | disclosed |
| US-20250032395-A1 | COPOLYMER THICKENING COMPOSITION COMPRISING AT LEAST ONE OIL AND AT LEAST ONE POLY(ITACONATE) FOR THICKENING POLAR OR APOLAR OILS | SOCIETE D’EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) | 2025-01-30 | — | — | US | disclosed |
| CN-117479922-A | Thickening composition for thickening polar or nonpolar oils | 化工产品开发公司SEPPIC | 2024-01-30 | — | — | CN | disclosed |
| CN-117479921-A | Copolymer thickening composition for thickening polar or non-polar oils comprising at least one oil and at least one poly (itaconate) | 化工产品开发公司SEPPIC | 2024-01-30 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250319013-A1 | THICKENING COMPOSITION FOR THICKENING POLAR OR NON-POLAR OILS | PHOSPHO1, ELOVL5, PARG | KDM4E 3943/4885DUSP3 4200/4885MEN1 1012/4885 |
| US-20250032395-A1 | COPOLYMER THICKENING COMPOSITION COMPRISING AT LEAST ONE OIL AND AT LEAST ONE POLY(ITACONATE) FOR THICKENING POLAR OR APOLAR OILS | SOAT1, NOTUM, CPT1A | KDM4E 4311/4885DUSP3 4535/4885MEN1 2183/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.